|[August 25, 2021]|
LINKOPING, Sweden, Aug. 25, 2021 /PRNewswire/ — International medical imaging IT and cybersecurity company Sectra (STO: SECT B) invites analysts, investors, and the media to a presentation of the company’s three-month report with President Torbjörn Kronander and CFO Mats Franzén.
Publication of the interim report: 8:15 a.m. (CEST) on September 3, 2021
Report presentation: 10:00 a.m. (CEST) on the same date
To participate, follow the instructions on Sectra’s website investor.sectra.com/q12122. The broadcast will also be made available on the same webpage after the conference.
Participation will take place via Microsoft Teams. Questions can be posed using the chat function or by sending questions in advance via email to email@example.com.
Sectra’s financial reporting calendar and Annual General Meeting
- September 9, 2021: Publication of the CEO’s address to the Annual General Meeting
- December 10, 2021 at 8:15 a.m. (CET): Six-month interim report
- March 9, 2022 at 8:15 a.m. (CET): Nine-month interim report
- June 3, 2022, at 8:15 a.m. (CEST): Year-end report 2021/2022
September 14, 2021: Annual General Meeting
For more information about Sectra’s financial events and reports: investor.sectra.com/events-and-presentations/
Subscribe for information
To subscribe for financial reports, invitations and information from Sectra via email, please fill in your contact information at investor.sectra.com/subscribe
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2020/2021 fiscal year totaled SEK 1,632 million. The Sectra share is quoted on the Nasdaq Stockholm exchange. For more information, visit Sectra’s website.
Chief Investor and Press Relations Officer
+46 (0) 13 23 52 04
This information was brought to you by Cision http://news.cision.com